Home Blog Page 1227

ViewSonic Unveils Industry’s First Android 16-Powered Interactive Displays and Education Ecosystem Innovations at Bett 2026

LONDON, Jan. 23, 2026 /PRNewswire/ — ViewSonic Corp., a leading global provider of visual and EdTech solutions, has showcased two new ViewBoard® series at Bett 2026, marking the industry’s first Android 16-powered interactive displays for education. Designed for fast responsiveness and reliable everyday use across modern academic spaces, both EDLA-certified series feature advanced 64-point multi-touch technology, as well as built-in ambient light and PIR motion sensors that support improved energy efficiency. In addition to the global hardware debut, ViewSonic has also presented its latest education software advancements, reinforcing its integrated ecosystem for both K–12 and higher education institutions.

ViewSonic showcases its Education Ecosystem at Bett 2026
ViewSonic showcases its Education Ecosystem at Bett 2026

“To deliver a trusted and reliable ecosystem that institutions can trust over the long term, ViewSonic remains focused on advancing products and solutions to keep pace with the needs of teaching and learning,” said Dennis Lin, General Manager of ViewSonic Education Solutions. “In response to educators’ expectations for secure and future-ready classroom technology, we are introducing the new ViewBoard series powered by the latest operating system. At Bett, we are also highlighting real-world school implementations to demonstrate how ViewSonic helps institutions improve teaching workflows and everyday learning experiences.”

Introducing the Newest ViewBoard Series

The EDLA-certified ViewBoard IFP35-1 Series* and ViewBoard IFP41-1 Series*, powered by Android 16, deliver precise and intuitive interaction through 64-point multi-touch technology and palm rejection. Built-in ambient light and PIR motion sensors support sustainability by automatically adjusting screen brightness and powering the display on when the classroom is in use and off when unoccupied.

The IFP41-1 Series is an advanced model optimized for discussion-based and collaborative learning. Featuring a complete speaker system with a subwoofer and microphone to support clearer communication and richer audio, together with Write Away instant annotation, the display supports seamless, real-time collaboration that enhances classroom interaction. With availability in five wide sizes ranging from 55 to 98 inches, the IFP41-1 Series supports diverse teaching space configurations across higher education, including lecture halls, seminar rooms, and hybrid learning spaces.

Powering Education Through Integrated Software and Ecosystem Innovations

Both of ViewSonic’s latest interactive display series are powered by the newly enhanced myViewBoard digital whiteboarding software, featuring a redesigned interface, real-time collaboration tools, Participate Mode for student engagement, and built-in accessibility features. The platform supports flexible lesson planning and seamless content integration across different formats and devices, allowing educators to easily adapt their teaching workflows.

At Bett 2026, ViewSonic has also showcased its scalable Education Ecosystem by combining myViewBoard with AirSync for seamless wireless casting and Manager for centralized IT control. Together, these solutions enable diverse deployment across classrooms and campus settings, helping institutions streamline teaching workflows and device management.

Real-World Deployments Across Primary, Secondary, and Higher Education

ViewSonic’s integrated solutions are already being deployed in real-world learning environments. Education institutions in the UK are adopting these solutions across diverse settings:

Visit ViewSonic at Booth #NK20, ExCel London by January 23 to experience first-hand how its scalable Education Ecosystem is being applied across classrooms and campuses. For more information, see ViewSonic’s Bett 2026 event page: https://www.viewsonic.com/uk/bett2026.

*Product availability may vary by region. Select models are expected to become available from Q2 to Q3 2026.

About ViewSonic 

Founded in 1987 and headquartered in Brea, California, ViewSonic is a leading global provider of visual solutions for the education, business, and consumer markets, with a presence in over 100 countries. Driven by the mission to transform education, workplaces, and lives, the company delivers a unified ecosystem of innovative hardware, software, and services that integrates seamlessly with the platforms, tools, and partners customers trust. Its product portfolio includes monitors, projectors, interactive displays, LED displays, commercial displays, video conferencing systems, and industrial solutions. Complementing its hardware is a robust suite of software offerings—including myViewBoard, ClassSwift, TeamOne, Manager, and AirSync—featuring AI-powered tools for collaboration, device optimization, and management. By empowering creativity, collaboration, and lifelong learning, ViewSonic supports customers at every stage in achieving their business and sustainability goals, creating a lasting impact and helping people everywhere connect with purpose—and See the Difference. Learn more at www.viewsonic.com.

ViewBoard IFP35-1 Series with Android 16 demonstrates rich and interactive teaching content using myViewBoard
ViewBoard IFP35-1 Series with Android 16 demonstrates rich and interactive teaching content using myViewBoard

Elvira Dyangani Ose Appointed Artistic Director of the Second Edition of Public Art Abu Dhabi Biennial

ABU DHABI, UAE, Jan. 22, 2026 /PRNewswire/ — The Department of Culture and Tourism – Abu Dhabi has appointed Elvira Dyangani Ose as Artistic Director of the Public Art Abu Dhabi Biennial to curate its second edition which opens in the autumn of 2026 and runs into 2027.

 

Elvira Dyangani Ose. Photographed by Emma Rahmani. Courtesy of Art Basel
Elvira Dyangani Ose. Photographed by Emma Rahmani. Courtesy of Art Basel

 

Building on the success of the inaugural edition that opened in 2024, the next edition of the Public Art Abu Dhabi Biennial, under Dyangani Ose’s direction, will transform Abu Dhabi once again into an emirate-wide celebration of public art, culture and community.

The much-lauded inaugural edition of Public Art Abu Dhabi Biennial, which exhibited throughout Abu Dhabi and Al Ain, ran from 15 November 2024 to 30 April 2025. The biennale featured site-specific installations by artists from the UAE and around the world, many of which were then acquired to remain as permanent public works including pieces by Kader Attia, Superflex, Nathan Coley, Wael Al Awar, Farah Al Qassimi and Shaikha Al Ketbi.

Elvira Dyangani Ose currently serves as Director of the MACBA, Museu d’Art Contemporani de Barcelona. Previously, she was Director and Chief Curator at The Showroom in London. Among other initiatives, she has held the roles of Curator of the eighth Gothenburg International Biennial for Contemporary Art, Senior Curator at Creative Time, and Curator of International Art at Tate Modern. She sat on the Advisory Council of Tate Modern and was a member of the Thought Council of Fondazione Prada, for whom she curated numerous exhibitions. She currently sits on the recently appointed Board of CIMAM – International Committee for Museums and Collections of Modern Art.

Her curatorial projects, multidisciplinary in nature, reflect critically on the narration of history as a participatory experience, the traces of collective representation in public space, and the recovery of non-Western narratives and epistemologies. Her recent projects include Project a Black Planet – The Art and Culture of Panafrica (co-curated, 2024 – 2027), Coco Fusco. I Learned to Swim On Dry Land (2025) and Goshka Macuga’s Miu Miu Tales and Tellers (convenor, 2024 – 2025).

Dyangani Ose holds a degree in Art History from the Universitat Autònoma de Barcelona. She is a doctoral candidate in Visual Studies at Cornell University in New York, where she earned a Master of Arts. She has a Diploma of Advanced Studies in Theory and History of Architecture from the Universitat Politècnica de Catalunya. She taught at Goldsmiths College as a specialist in Museology, Curating, Black Studies, and Contemporary African Art.

Further details and dates relating to the second edition of Public Art Abu Dhabi Biennial will be announced in due course.

Notes To Editors

About Public Art Abu Dhabi

Public Art Abu Dhabi is the Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi)’s initiative under its ongoing commitment to commissioning public art for the emirate. Integral to this initiative is its community engagement efforts. The initiative advances the creative legacy, cultural infrastructure, liveability, and wellbeing of the UAE capital’s residents through placemaking and collective memory. Public Art Abu Dhabi presents the Public Art Abu Dhabi Biennial along with Manar Abu Dhabi.

For more information please visit: paad.ae 

About the Department of Culture and Tourism – Abu Dhabi:

The Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi) drives the sustainable growth of Abu Dhabi’s culture and tourism sectors and its creative industries, fuelling economic progress and helping to achieve Abu Dhabi’s wider global ambitions.

By working in partnership with the organisations that define the emirate’s position as a leading international destination, DCT Abu Dhabi strives to unite the ecosystem around a shared vision of the emirate’s potential, coordinate effort and investment, deliver innovative solutions, and use the best tools, policies and systems to support the culture and tourism.

DCT Abu Dhabi’s vision is defined by the emirate’s people, heritage and landscape. We work to enhance Abu Dhabi’s status as a place of authenticity, innovation, and unparalleled experiences, represented by its living traditions of hospitality, pioneering initiatives and creative thought.

For more information about the Department of Culture and Tourism – Abu Dhabi and the destination, please visit: dct.gov.ae and abudhabiculture.ae

Hydrexia to Provide Hydrogen Application Solution to Toyota

SIDNEY, Jan. 22, 2026 /PRNewswire/ — Hydrexia Pty Ltd, the wholly owned subsidiary of Hydrexia Holding Limited (Hydrexia), a leading hydrogen technology solution provider, announced today that it has secured an order to provide The Toyota Motor Corporation Australia Ltd (TMCA) with a number of relocatable hydrogen refuelling stations (RHRSs) to support hydrogen-powered fuel cell electric vehicles in the Australian market.

The agreement covering the supply, operation and maintenance of refuelling equipment expands on previous successful collaboration between Hydrexia and Toyota and follows the successful deployment of refuelling stations to UMW Toyota in Malaysia and Toyota Philippines. Hydrexia is proud to continue its support for Toyota’s leadership and significant commitment towards decarbonisation in the mobility sector.

“Australian consumers will continue to benefit from a wider choice of vehicles and technologies, which requires ongoing market leadership in driving this change and TMCA has shown its commitment to making this a reality,” said Ashley Mills, the managing director of Hydrexia Pty Ltd.  “Hydrexia is proud offer the necessary infrastructure and support to enable this change”.  “We are highly appreciative of the trust TMCA has placed in Hydrexia to match its customer service commitments,” Mills added.

Hydrexia has rapidly expanded its international business operation across Southeast Asia, Europe, the U.S., and Australia. This latest project represents yet another significant step in Hydrexia’s growing presence in the Australian hydrogen market over the past 12 months.

About Hydrexia

Hydrexia Holding Limited is a leading integrated hydrogen technology solution provider in China with global reach. The company specializes in providing technology solutions for hydrogen production, storage, transportation, and end-use applications. Leveraging its solid R&D capabilities and industry-leading technology, Hydrexia aims to effectively address the technology and application needs across the global hydrogen industry value chain.

Deltek Global Partner Awards Recognize Partners Driving Measurable Customer Outcomes

Honorees span government contracting, architecture, engineering, consulting, and professional services industries, driving innovative and mission-critical results worldwide

HERNDON, Va., Jan. 22, 2026 /PRNewswire/ — Deltek, the intelligent platform for project-based businesses, today announced the winners of this year’s Deltek Global Partner Awards, recognizing partners that have demonstrated exceptional performance, innovation, and customer impact across its global network.

The annual awards celebrate organizations of all sizes that collaborate with Deltek to help project-based businesses modernize operations, improve outcomes, and deliver mission-critical work with greater confidence. This year’s honorees reflect excellence across key industries, including government contracting, architecture and engineering, consulting, and professional services.

Celebrating Excellence in the Deltek Partner Ecosystem

The Deltek Global Partner Awards honor organizations that collaborate with Deltek to significantly contribute to customer success and the broader project-based business community. Recipients are evaluated based on:

  • Customer outcomes and testimonials
  • Innovation and product adoption
  • Business growth and performance metrics
  • Thought leadership and market influence

2025 Deltek Global Partner Awards

  • Collaboration Partner of the Year: Infotek
  • Rising Star Partner of the Year: CrunchTech
  • Innovation Partner of the Year: Silversoft
  • Services Partner of the Year: Baker Tilly
  • Cloud Migration Partner of the Year: Infotek
  • International Partner of the Year: Silversoft
  • Government Contracting Resell Partner of the Year: PCI
  • Deltek Resell Partner of the Year: Full Sail Partners
  • Marketplace Partner of the Year: Vroozi

“Across government contracting, architecture and engineering, consulting, and professional services, the Deltek partner ecosystem is helping our customers modernize how they deliver projects while continuously raising the bar,” said Mike Byrd, Vice President, Global Partners and Alliances at Deltek. “Our work wouldn’t be possible without these incredible partners and their remarkable achievements. Together with this vibrant community, we’re innovating to deliver measurable outcomes so that project-based businesses worldwide can run mission-critical projects with greater speed, clarity, and control.”

Recognizing Outstanding Partners

Deltek’s partner network plays a critical role in helping organizations transform operations and maximize their business potential. This year, the awards spotlight partners who excelled in:

  • Solution delivery
  • Customer service and support
  • Industry leadership
  • Innovation in project-based software

Benefits of the Deltek Partner Ecosystem

Deltek partners gain access to a comprehensive set of enablement resources designed to accelerate growth and enhance customer value, including:

  • Training and Enablement: In-depth education, certifications, and continuous learning
  • Advanced Tools: Access to Deltek platforms, tech innovations, and integration resources
  • Go-to-Market Support: Co-selling, joint marketing, and lead-generation opportunities
  • Global Community: Knowledge sharing, networking, and international visibility
  • Exclusive Insights: Early access to product updates, industry trends, and best practices

This ecosystem empowers partners to deliver high-impact solutions and stand out as trusted advisors in their industries.

About Deltek

Deltek is the intelligent platform that powers the project lifecycle—from ERP and accounting to project bidding, planning, delivery, and analysis. Trusted by 30,000 organizations across government contracting, aerospace and defense, architecture and engineering, construction, and consulting, Deltek delivers the speed, clarity, and control needed when the stakes are high. Learn more at www.deltek.com.

CONTACT: press@deltek.com 

BestQool Reveals Black Friday Consumer Trends: Flexibility and Performance Shape Red Light Therapy Purchases

NEW YORK, Jan. 22, 2026 /PRNewswire/ — As red light therapy continues to integrate into everyday wellness routines, Black Friday 2025 provided insight into evolving consumer behavior.

Sales of BestQool’s red light panel lights, represented by the BQ60 and Pro300, maintained strong growth during Black Friday 2025, demonstrating that panel lights remain a highly competitive category driving growth in red light therapy.
Sales of BestQool’s red light panel lights, represented by the BQ60 and Pro300, maintained strong growth during Black Friday 2025, demonstrating that panel lights remain a highly competitive category driving growth in red light therapy.

BestQool‘s analysis of its Black Friday sales data indicates solid year-over-year growth in North American and European markets, along with gradual shifts in consumer preferences toward device form factor, usage flexibility, and performance—reflecting changing purchase considerations at the end of 2025.

Key consumer trends in red light therapy

Mobility Solutions Become Key Consideration in Red Light Therapy

The Mobile stand designed by BestQool is to accommodate large panel lights of various sizes from most brands; with a simple, sturdy mounting structure and an integrated caster system, it significantly improves the mobility of panel lights. During BestQool’s 2025 Black Friday promotion, orders for Mobile stand increased eightfold in total order share compared with 2024. This growth reflects a growing awareness among consumers of the awkward and impractical experience of using large panel lights in home environments.

Wearable Formats Gain Share at Comparable Budget Levels

BestQool’s Redot series focuses on delivering red light sessions through belt and mat form factors, including the Redot S for abdominal use, the larger Redot M suitable for the neck, shoulders, or lower back, and the half-body-sized Redot L. During Black Friday 2025, while being promoted alongside the similarly priced BQ series, Redot series sales increased by 1.2× compared with the same period in 2024. At the same time, its share of total promotional sales doubled year over year. This shift indicates a growing consumer preference for more flexible device formats when budget levels are comparable.

Panel Lights Remain the Primary Product Category by Sales

“Are panel lights still the most central pillar of BestQool’s brand appeal? —Without question,” said CEO Jacob.

BestQool’s panel light lineup consists of two series: the entry-level BQ series and the higher-budget professional Pro series. Represented by the BQ60, the BQ series delivers strong dual-wavelength output in a compact, portable form factor, while the Pro series—exemplified by the Pro300—offers four wavelengths designed to support deeper tissue coverage across a half-body area. Both series provide highly competitive performance within their respective price ranges, making them representative products within the panel light category. Despite expansion in other product types, BestQool panel light sales during Black Friday 2025 reached 1.5 times the volume recorded during Black Friday 2024, reaffirming panel lights as the most widely adopted red light device.

From trends to long-term value

The consumer shifts observed during Black Friday reflect red light therapy’s transition from a single-device purchase toward a long-term wellness solution that prioritizes sustained use and lifestyle compatibility. With stable output as its foundation and increasingly flexible, user-oriented design, BestQool continues to narrow the distance between red light technology and everyday life—helping users realize the long-term value of red light therapy in a sustainable, routine-friendly way.

About BestQool

BestQool’s mission is to bring clinically validated light therapy into daily routines. By combining user-centered design with advanced product iteration, the company provides safe and effective red light therapy technology for personal care and small professional environments.

Media Contact
Giselle
marketing@bestqool.com

Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines

  • New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM
  • Up to 10x performance gains on key drug discovery benchmarks compared to LLMs that miss the mark on ~75–95% of tasks
  • Advances Insilico’s vision of Pharmaceutical Superintelligence (PSI)

CAMBRIDGE, Mass., Jan. 22, 2026 /PRNewswire/ — Insilico Medicine (“Insilico”, HKEX: 3696), a leading global AI-driven biotech company with a clinical-stage pipeline, today announced the launch of Science MMAI Gym, a domain-specific training environment designed to transform any causal or frontier Large Language Model (LLM) into a high-performance engine for real-world drug discovery and development tasks.

Building on more than a decade of AI research and its own internal pipeline of 27 preclinical candidates, 10+ molecules with IND clearance, and multiple Phase I and Phase IIa clinical trials completed or ongoing, Insilico is now opening its AI training infrastructure to external partners. Science MMAI Gym adapts general-purpose LLMs (such as GPT, Claude, Gemini, Grok, Llama, and Mistral) to reason in medicinal chemistry, biology, and clinical development with the precision required in modern pharma R&D.

Alex Zhavoronkov, PhD, founder, CEO and CBO of Insilico Medicine invites pharma and biotech companies, AI labs, and cloud providers to “bring your AI model to Science MMAI Gym” and explore CSI, BSI, and PSI memberships tailored to their R&D pipelines.

Addressing the LLM Performance Gap in Drug Discovery

Despite their general intelligence, flagship LLMs often fail or underperform on mission-critical drug discovery tasks, such as predicting complex pharmacokinetic (DMPK) and toxicity endpoints (e.g., hERG, DILI risk, LD50). Insilico’s benchmarks show that without specialized training, general models often produce vague or chemically implausible reasoning, even with advanced prompting.

Science MMAI Gym directly addresses this by teaching LLMs domain-specific scientific reasoning—the language, formats, and conceptual chains used by chemists and biologists rather than treating drug discovery as a simple NLP benchmark.

The Gym’s curriculum focuses on:

  • Medicinal and organic chemistry: Multi-step optimization chains, reaction reasoning, retrosynthesis, and 3D structure-property relationships.
  • Biology and target discovery: Omics-aware reasoning over gene expression, pathways, disease mechanisms, and multi-objective target scoring.
  • Clinical development: Interpretation of trial designs, endpoints, and prediction of Phase 2 trial success or failure using proprietary benchmarks like ClinBench.

The Training Architecture: CSI and BSI

Science MMAI Gym is a core component of Insilico’s roadmap toward Pharmaceutical Superintelligence (PSI), with dedicated tracks for Chemical Superintelligence (CSI) and Biology/Clinical Superintelligence (BSI).

Models “train” in the Gym over a period of weeks to months using:

  1. High-quality, domain-specific reasoning datasets: Leveraging millions of internal data points, including over 4 million medicinal chemistry optimization chains, 100 million organic synthesis descriptions, and hundreds of thousands of molecular dynamics trajectories.
  2. Multi-task Fine-Tuning and Reinforcement Learning: Models undergo Multi-task Supervised Fine-Tuning (SFT) and Reinforcement Fine-Tuning (RFT) using reward models to hone reasoning skills and align predictions with experimental outcomes.
  3. Robust Benchmarking: Each cycle is evaluated against public and in-house out-of-distribution (OOD) benchmarks, including TDC, TargetBench, and ClinBench, ensuring the model’s performance is robust for real-world application.

Case Studies: From Generalist to Specialist

Internal benchmarks demonstrate the transformative effect of the Gym:

  • Chemistry (CSI): A tested open-source causal LLM, which previously failed on 70% of medchem tasks, emerged from the Gym as a “single-model-does-it-all” chemistry engine. It achieved SOTA or near-SOTA performance on multiple ADMET tasks and delivered SOTA Success Rate on five optimization tasks in the MuMO-Instruct benchmark, matching or exceeding strong category-specific generalist models.
  • Biology/Clinical (BSI): Models trained at the Gym demonstrated substantial gains on proprietary benchmarks. On ClinBench, a model’s F1 score for predicting Phase 2 trial outcomes rose significantly, outperforming a broad set of frontier LLMs. Similarly, on TargetBench, BSI-tuned models achieved the top composite ranking for novel target identification across multiple diseases, demonstrating high biological plausibility and translational readiness.

Business Model: “Membership” in the AI GYM for Science

Science MMAI Gym is offered as a flexible, membership-style program, ranging from intensive two-week sprints to longer PSI-oriented engagements. Partners provide their base model and receive a CSI/BSI/PSI-enhanced version with up to 10x performance improvement compared to baseline, along with detailed benchmark reports and optional wet-lab validation through Insilico’s automated assay platforms.

About Insilico Medicine

Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend health longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.HK.

By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma.AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine. For more information, please visit www.insilico.com

 

IFS delivers exceptional FY2025 growth as Industrial AI scales from first deployment to commercial impact

Market-leading ARR growth, margin expansion and net retention underscore accelerating adoption of purpose-built Industrial AI

Key highlights FY2025

  • Annual Recurring Revenue (ARR): +23% YoY 
  • Cloud Revenue: +30% YoY
  • Recurring Revenue: 83% of total revenue
  • Net Retention Rate (NRR): 114%
  • Operating Margin Expansion: +5pp YoY

LONDON, Jan. 22, 2026 /PRNewswire/ — IFS, the leading provider of Industrial AI software, today announced its financial results for the fiscal year ending December 31, 2025, delivering 23% year-on-year ARR growth, strong margin expansion and increasing customer expansion as Industrial AI moves decisively from experimentation to scaled operational deployment.

IFS’s FY2025 performance reflects a fundamental shift in the industrial software market. The world’s largest asset-intensive and service-centric enterprises are no longer asking whether AI works – they are scaling solutions that deliver measurable outcomes across manufacturing, asset maintenance, supply chain, field service and warehouse operations.

Industrial AI delivering real-world outcomes at scale

IFS’s Industrial AI platform is delivering production-grade results where generic AI approaches fall short. Customers typically begin with targeted operational use cases, achieve rapid ROI, and then expand deployments across additional sites, assets, and business units.

This expansion dynamic drove:

  • 114% Net Retention Rate,
  • 14% YoY growth in average deal size, and
  • Continued improvement in customer lifetime value, supported by an 87% CSAT score.

IFS’s innovation velocity enables customers to realize value quickly:

  • IFS Nexus Black™ delivers breakthrough AI capabilities within weeks by turning customer challenges into productized innovation.
  • IFS Agent Studio allows enterprises to create and deploy Agentic Digital Workers, embedding automation and intelligence deep into mission-critical operations.

Strategic partnerships with leading innovators including Anthropic, Microsoft, Siemens and Boston Dynamics further accelerate progress toward autonomous operations.

This differentiated approach is why leading companies are scaling their Industrial AI journeys with IFS. Major FY2025 customer wins and expansions include: ArcelorMittal, Cadillac Formula 1 Team, Callaway, Collins Aerospace, Dixstone, Hitachi Energy, Homeserve, Japan Airlines, Tampa Electric (TECO), TotalEnergies, Westinghouse, and William Grant & Sons.

Strategic acquisitions expand Industrial AI leadership

During 2025, IFS significantly expanded its Industrial AI capabilities and market reach through targeted acquisitions:

  • TheLoops – delivering the first Agentic AI workforce purpose-built for mission-critical industries, with early deployments demonstrating the potential to unlock up to 10× workforce capacity.
  • 7Bridges – adding AI-driven supply chain and transportation optimization, with early customers achieving 8% transport cost reductions and 90% automation of data management tasks.
  • Softeon (expected to close in Q1 2026) – extending Industrial AI into warehouse management and robotics integration, enabling end-to-end supply chain orchestration.

Previously acquired businesses including Copperleaf, Poka and Ultimo also contributed materially to FY2025 growth and differentiation.

Profitable growth, disciplined execution

IFS combined strong growth with improved profitability in FY2025. Operating margin expanded by 5 percentage points year-on-year, reflecting disciplined execution, increasing scale benefits and a growing mix of high-quality recurring revenue. 

Mark Moffat, Chief Executive Officer, IFS, said: “FY2025 was the year Industrial AI crossed the chasm. Enterprises have moved beyond pilots and are scaling AI across the operations that matter most. Customers are choosing IFS because our technology is purpose-built for industrial complexity and delivers outcomes at scale – as customers see ROI, they expand faster and commit more deeply. IFS’s growth is double that of peers when compared to market growth figures published by respected industry analysts*. We’re accelerating as we enter 2026, and the gap is widening.”  

Matthias Heiden, Chief Financial Officer, IFS, added: “Our results demonstrate the quality of IFS’s growth. ARR increased 23%, NRR reached 114%, and operating margin expanded by 5 percentage points year-on-year. With 83% of revenue now recurring, we have strong visibility and a resilient financial foundation to continue investing in innovation while maintaining profitability.”

Market recognition and outlook

IFS’s leadership continues to be recognized by industry analysts, including multiple Gartner Peer Insights Customers’ Choice awards and leadership positions in Gartner Magic Quadrants and IDC MarketScapes across asset management, field service, and ERP. 

Looking ahead, IFS will build on its FY2025 momentum by embedding Industrial AI more deeply into day-to-day operations – from warehouses and supply chains to field service and asset maintenance – helping customers unlock faster, more predictable outcomes at scale.

Micky North Rizza, Group Vice-President at IDC, said: “IFS’s FY2025 results underscore a broader inflection point in the industrial software market, where AI is moving decisively from experimentation to scaled, operational deployment. The combination of strong recurring revenue growth, expanding cloud adoption, and targeted acquisitions signals that industrial enterprises are prioritizing purpose-built platforms that can deliver measurable outcomes across asset-intensive and service-centric operations. This positions IFS well as organizations seek resilient, industry-specific AI capabilities rather than generic enterprise solutions.”

*Gartner Market Share Analysis: ERP Software, Worldwide, 2024 (published June 2025)

IFS Press Contacts:

EUROPE / MEA / APJ: Adam Gillbe
IFS, Director of Corporate & Executive Communications
Email: adam.gillbe@ifs.com 

NORTH AMERICA / LATAM: Mairi Morgan
IFS, Director of Corporate & Executive Communications
Email: mairi.morgan@ifs.com 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/ifs/r/ifs-delivers-exceptional-fy2025-growth-as-industrial-ai-scales-from-first-deployment-to-commercial-i,c4296429

The following files are available for download:

 

Mindray Unveils Three-Pillar Growth Strategy at 2026 J.P. Morgan Healthcare Conference, Paving the Way for Next Decade of Global Healthcare Innovation

SHENZHEN, China, Jan. 22, 2026 /PRNewswire/ — May Li, Board Secretary of Mindray Medical (300760.SZ), delivered a keynote speech at the 44th J.P. Morgan Healthcare Conference (JPM Conference) on January 15, 2026, outlining the company’s strategic vision for the next decade centered on three core pillars: Globalization, Recurring Business Expansion, and Intelli-Digitalization. The speech also showcased significant progress in Mindray’s Large Language Model (LLM) product family and innovative solutions that are redefining clinical excellence worldwide.

May Li, Board Secretary of Mindray Medical, delivered a keynote speech at the 44th J.P. Morgan Healthcare Conference.
May Li, Board Secretary of Mindray Medical, delivered a keynote speech at the 44th J.P. Morgan Healthcare Conference.

Globalization: Deepening Localization to Expand International Footprint

With a 25-year foundation in global business, Mindray has built a robust international infrastructure spanning over 40 countries, including 64 subsidiaries, 5 R&D centers, and 14 manufacturing facilities. Its international workforce has grown to over 3,000 employees, 90% of whom are locally recruited, supporting a 15% compound annual growth rate in international business over the past decade. Currently, international revenue accounts for 50% of the company’s total, and Mindray aims to increase this proportion to over 60% through further investment in localization.


Beyond traditional sales and marketing localization, Mindray is committed to building local healthcare capacity, particularly in emerging markets. In the Middle East and Africa, for example, the company has established over 20 ultrasound training institutes, certifying thousands of local clinicians to deliver quality diagnostic services. By expanding local manufacturing, supply chain sourcing, and R&D operations, Mindray is positioning itself as a trusted strategic partner for healthcare stakeholders globally, rather than just a medical device supplier.

Recurring Business Expansion: Tapping High-Growth Segments with Technological Innovation

Recurring business, including IVD reagents, high-value consumables, IT solutions, and customer services, already contributed 40% of Mindray’s total revenue in the first half of 2025. The company targets lifting this contribution to over 50%, leveraging significant growth potential in underpenetrated markets. In 2024, Mindray held less than 15% market share in China’s addressable IVD market and around 4% globally, while its share in the global minimally invasive surgery (MIS) and minimally invasive intervention (MII) markets was only 0.8%.


To accelerate growth, Mindray is establishing localized supply chains and manufacturing facilities for recurring business outside China, enabling faster response to customer needs and deeper penetration into high-end segments. The company’s product roadmap includes expanding into a comprehensive “pan-interventional therapy” ecosystem covering percutaneous, transnatural orifice, and transrespiratory tract approaches, following its entry into cardiovascular intervention via the acquisition of APT Medical. In MIS, Mindray plans to extend beyond thoracic and general surgery to gynecology and urology, with a focus on developing specialized surgical robots.

Technological innovation is driving progress in recurring business lines. In IVD, Mindray’s next-generation Estradiol detection reagent based on SEMS (Single Epitope Meta-Sandwich) technology offers exceptional drug interference resistance and nearly 100% linearity with mass spectrometry results, addressing critical unmet needs in breast cancer endocrine therapy. Its high-sensitivity cardiac troponin I assay reduces misdiagnosis risk by 50-fold, enhances anti-interference performance by 20-fold, and cuts patient observation time by 50%, with outcomes published in 16 top-tier medical papers. In MIS consumables, the intelligent stapler with Tissue Real-time Sense algorithm and ultrasonic scalpels featuring Smart Tissue Sensing and Enhanced Vessel Sealing technologies deliver precise, safe clinical outcomes.

Intelli-Digitalization: Breaking the Healthcare “Impossible Trinity” with Integrated Ecosystem 

Mindray’s Intelli-Digitalization pillar aims to build an integrated “Device + IT + AI” ecosystem, addressing the universal healthcare trilemma of balancing Quality, Access, and Cost—long considered an “Impossible Trinity.” By automating mundane administrative tasks, the company’s solutions free up healthcare staff to focus on direct patient care, restoring “time for healing.”

The Intelli-Digital solution comprises five interconnected layers:

1. Foundational Layer: Industry-leading medical devices (patient monitors, ultrasound systems, anesthesia machines, etc.) generating high-quality clinical data.

2. Device Convergence Layer: Integration of traditionally isolated devices (e.g., combined intravenous-inhalation anesthesia, endoscope-ultrasound image fusion) to streamline workflows and reduce errors.

3. IT System Layer: Unified platforms including miCare (patient monitoring), miImaging (ultrasound), miInnolab (IVD), as well as CIS, LIS, and PACS, organizing fragmented data across devices.

4. AI Layer: The Qi Yuan LLM family, launched in late 2024, now expanded from critical care to perioperative care, breast health, OBGYN, and laboratory settings. Deployed on-premises to protect patient privacy, Qi Yuan creates digital patient twins, enables 24/7 real-time monitoring, and automates clinical documentation, acting as a virtual clinical partner in high-stakes scenarios. 


5. Future Development Layer: Ongoing innovations to be unveiled in coming phases.

Real-world case studies demonstrate the impact of these solutions:

  • At Akershus University Hospital in Norway, miCare integrated with mWear wearable devices reduced ICU overcrowding, cut Rapid Response Team interventions by enabling early acute illness detection, and simplified data transmission to EMR systems—while extending monitoring to post-discharge patients at home.
  • In Saudi Arabia, miImaging powers Seha Virtual Hospital (SVH), the world’s largest online virtual hospital handling 400,000+ annual cases, enabling remote ultrasound consultations and bridging gaps between primary care clinics and specialist expertise.
  • China’s Jiangyou Regional Clinical Laboratory Center, using miInnolab, implemented a “2+6+X” model connecting 31 laboratories, achieving seamless data interoperability and unified diagnostic standards—recognized as a national model for regional healthcare collaboration.
  • At Shanghai Renji Hospital’s East Campus, Qi Yuan LLM reduced liver transplant surgery time by ~50% while enhancing safety and diagnostic efficiency, serving as a blueprint for expanding intelligent hospital models to 20 major overseas countries.

Vision: Better Healthcare for All Through Intelligent Innovation

Mindray’s three core pillars are aligned with its mission to “Better healthcare for all.” Globalization expands access to innovative solutions, recurring business ensures long-term profitability for sustained R&D, and Intelli-Digitalization addresses the industry’s most pressing challenges. Looking ahead, the company plans to develop fully automated “lights-out factories” for laboratories and deploy intelligent anesthesia and ultrasound robots, further advancing embodied intelligence in healthcare.

“Our integrated ecosystem redefines the relationship between Device, IT, and AI—treating them as a seamless whole to turn data into actionable clinical insights,” said May Li. “By breaking the ‘Impossible Trinity,’ we are making healthcare more precise, accessible, and efficient globally, solidifying our position as a leader in medical technology.”

Mindray (300760.SZ) remains committed to driving healthcare innovation through its three strategic pillars, unlocking untapped potential in core and emerging business segments to deliver better care for patients worldwide.